Trial Profile
A study investigating the effect and adherence of travoprost when in given in morning or evening in patients with glaucoma or ocular hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Travoprost (Primary)
- Indications Glaucoma; Ocular hypertension
- Focus Therapeutic Use
- 11 Dec 2015 New trial record